COGT — Cogent Biosciences, Inc. stock price, charts and financials

QT63Cogent Biosciences, Inc.

Cogent Biosciences, Inc. (NASDAQ: COGT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
42.84
+3.98+10.24%
OverviewShort InterestFilings
COGTQT63Cogent Biosciences, Inc.·NASDAQ
42.84+10.24%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 06, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20268-KCurrent report
May 21, 20264Statement of changes in beneficial ownership
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 05, 20268-KCurrent report
May 05, 202610-QQuarterly report
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 23, 2026ARSAnnual report to shareholders
Apr 03, 20264Statement of changes in beneficial ownership
Mar 31, 20264Statement of changes in beneficial ownership
Mar 31, 2026144Notice of proposed sale of restricted securities
Mar 31, 2026SC 13D/ABeneficial ownership statement (active, amended)
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 17, 20268-KCurrent report
Feb 17, 2026S-8Registration of employee benefit securities
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 312
Page
▼
/ 13